Uterine Cancer PDX Models

Patient-derived xenograft (PDX) models display a true representation of the human heterogeneity of gynecologic malignancies and provide the most accurate approach to predicting an agents efficacy prior to entering the clinic. The CrownBio uterine cancer PDX collection consists of several models including ER+ and estrogen dependent models. More

PDX offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, PDX models reflect the heterogeneity and diversity of the human patient population. PDX give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials. CrownBio’s HuPrime® PDX models are well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.
UT14024Uterine CancerNAVIEW MODEL
UT14026Uterine CancerNAVIEW MODEL
UT3617Uterine CancerEndometrialVIEW MODEL
UT3759Uterine CancerEndometrialVIEW MODEL
UT3778Uterine CancerEndometrialVIEW MODEL
UT5317Uterine CancerEndometrial, (ER+)VIEW MODEL
UT5318Uterine CancerEndometrial, (ER-)VIEW MODEL
UT5319Uterine CancerEndometrial, (ER+)VIEW MODEL
UT5320Uterine CancerEndometrial, (ER-)VIEW MODEL
UT5321Uterine CancerEndometrial, (ER+)VIEW MODEL